MARC21

000	00000nam 2200000zi 4500
001	9.924899
003	CaOODSP
005	20240311151556
006	m o d f
007	cr \|\|\|\|\|\|\|\|\|\|\|
008	230710t20232023onc o f00\| 0 eng d
020	\|a9780660494289
040	\|aCaOODSP\|beng\|erda\|cCaOODSP
043	\|an-cn---
086	1 \|aH14-443/2023E-PDF
245	00\|aMpox immunization coverage survey among 2SLGBTQI+ and men who have sex with men : \|bmethodological report.
264	1\|a[Ottawa] : \|bPublic Health Agency of Canada = Agence de la santé publique du Canada, \|c2023.
264	4\|c©2023
300	\|a1 online resource (33 pages) + \|eexecutive summary (5 pages)
336	\|atext\|btxt\|2rdacontent
337	\|acomputer\|bc\|2rdamedia
338	\|aonline resource\|bcr\|2rdacarrier
500	\|aIssued also in French under title: Enquête sur la couverture vaccinale contre la variole simienne chez les 2SLGBTQI+ et les hommes ayant des rapports sexuels avec des hommes : rapport méthodologique.
500	\|a"Supplier name: Advanis Inc."
500	\|a"Contract number: 6D142-226171."
500	\|a"Registration number: POR 139-22."
520	\|a"The purpose of this survey was to provide information on mpox vaccine coverage for the 2SLGBTQI+ as well as MSM adult populations, and to help understand the knowledge, attitudes, and beliefs concerning mpox vaccines (e.g., vaccine effectiveness, vaccine safety, vaccine relevance). This includes exploring reasons for vaccine hesitancy and vaccine refusal and the impact this has on vaccine uptake as well as obstacles for non-vaccination of mpox. Its purpose was also to identify risk factors for transmission of mpox as well as these populations’ willingness to limit high-risk activities amid the current mpox outbreak"--page 4.
650	0\|aHuman monkeypox\|xVaccination\|zCanada\|xPublic opinion.
650	0\|aPublic opinion\|zCanada.
650	0\|aSexual minorities\|zCanada\|xAttitudes.
710	2 \|aPublic Health Agency of Canada, \|eissuing body.
710	2 \|aAdvanis (Firm), \|econsultant.
775	08\|tEnquête sur la couverture vaccinale contre la variole simienne chez les 2SLGBTQI+ et les hommes ayant des rapports sexuels avec des hommes : \|w(CaOODSP)9.924902
794	\|tMpox immunization coverage survey among 2SLGBTQI+ and men who have sex with men, 2024 : \|w(CaOODSP)9.935235
856	40\|qPDF\|s994 KB\|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-443-2023-eng.pdf\|zMethodological Report
856	40\|qPDF\|s373 KB\|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-443-2023-1-eng.pdf\|zExecutive Summary
856	4 \|qHTML\|sN/A\|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/139-22-e/139-22_report.html\|zMethodological Report
856	4 \|qHTML\|sN/A\|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/139-22-e/summary/139-22_summary.html\|zExecutive Summary